Personalis Total Assets 2018-2025 | PSNL

Personalis total assets from 2018 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Personalis Annual Total Assets
(Millions of US $)
2024 $270
2023 $225
2022 $293
2021 $397
2020 $245
2019 $157
2018 $42
2017 $0
Personalis Quarterly Total Assets
(Millions of US $)
2025-03-31 $273
2024-12-31 $270
2024-09-30 $240
2024-06-30 $186
2024-03-31 $195
2023-12-31 $225
2023-09-30 $227
2023-06-30 $249
2023-03-31 $272
2022-12-31 $293
2022-09-30 $318
2022-06-30 $358
2022-03-31 $381
2021-12-31 $397
2021-09-30 $407
2021-06-30 $383
2021-03-31 $396
2020-12-31 $245
2020-09-30 $249
2020-06-30 $146
2020-03-31 $152
2019-12-31 $157
2019-09-30 $160
2019-06-30 $192
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2017-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.415B $0.085B
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.579B 7.44
Dr Reddy's Laboratories (RDY) India $12.154B 22.06
BridgeBio Pharma (BBIO) United States $6.126B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.800B 14.61
Bausch Health Cos (BHC) Canada $1.658B 1.21
Amphastar Pharmaceuticals (AMPH) United States $1.200B 7.99
Taysha Gene Therapies (TSHA) United States $0.524B 0.00
Assembly Biosciences (ASMB) United States $0.105B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00